According to the U.S. News & World Report, NewYork-Presbyterian is home to New York’s top ranked Diabetes & Endocrinology program.
The Centers for Diabetes Care at NewYork-Presbyterian take an active role in using innovative treatments and educating the public on how to prevent this chronic disease. They also address a wide range of metabolic and endocrine disorders, including primary hyperparathyroidism, osteoporosis, transplantation-related bone disease, and Paget's Disease. The Naomi Berrie Diabetes Center at NewYork-Presbyterian/Columbia University Irving Medical Center is one of three Diabetes Centers of Excellence in New York State and has been cited by the American Diabetes Association for its quality care.
Exploring Novel Treatments for Thyroid Cancer
Under the direction of Dr. Thomas J. Fahey, III, researchers at Weill Cornell Medicine have identified the use of gene expression analysis to discriminate benign and malignant thyroid nodules.
Interventional Endocrinology: An Emerging Specialty
Doctors at NewYork-Presbyterian/Columbia are looking to interventional endocrinology, an emerging specialty that uses percutaneous, image-guided, less-invasive procedures to address endocrine disorders that offers an alternative to surgery.
Managing the Challenges of Pregnancy and Diabetes
Physicians at Weill Cornell Medicine reviewed the diagnostic criteria for diabetes in pregnancy; types of therapies available to prevent hyperglycemia; and strategies for reaching inpatient glycemic targets during the peripartum period.
Meeting the Pressing Need for Evidence-Based Obesity Care
Research is a key component of the Weight Control Center. Dr. Korner is the principal investigator of an NIH-funded study to understand the hormonal regulation of appetite and energy balance.
Pathways to Diabetes Prevention: It’s All Relative
We found that insulin production decreases long before a patient is actually diagnosed with type 1 diabetes. Now that we know that a reduction in insulin production begins earlier on, we can diagnose T1D earlier in patients with antibody screening. So the question became how do we reach these individuals.
Regulating Metabolism in the Setting of Cancer
Dr. Goncalves has developed a mouse model that recapitulates the cachexia syndrome as they seek interventions – either dietary or metabolic – to help prevent muscle wasting and fat loss.
Newsletters for Medical Professionals
2021 Issue 2
- Active Surveillance: A Rational Option in Monitoring Low-Risk Thyroid Cancer
- COVID-19 and Diabetes: Importance of Glycemic Management
2021 Issue 1
- Uncovering the Relationship Between COVID-19 and Obesity
- Answering the Call: Fellows Redeployed to Aid During Pandemic
- Exploring Novel Treatments for Thyroid Cancer
- Interventional Endocrinology: An Emerging Specialty
- Dr. Laura Alonso New Chief of Endocrinology at Weill Cornell
- Enhancing Endocrinology Education for Physicians and Patients
- Managing the Challenges of Pregnancy and Diabetes
- Meeting the Pressing Need for Evidence-Based Obesity Care
- Noted Endocrinologist Appointed Chair of Department of Medicine at Weill Cornell
- Obesity: Advancing Treatment Through Clinical Trials
- On the Front Lines of Diabetes Prevention and Treatment
- Type 1 Diabetes: It’s Professional and Very Personal